STADA
English (United Kingdom)
en
  • Thai (Thailand)
    ไทย (TH)
stada.com
  • About STADA
  • Products
  • Contact
  • Who we are – STADA Thailand
  • Management
  • Our Corporate Culture
Who we are – STADA Thailand

Who we are – STADA Thailand

Management

Management

  • Products overview
  • Quality at STADA TH
Products overview

Products overview

Quality at STADA TH

Quality at STADA TH

STADA
  • English (United Kingdom)
    en (Change Language)
    Back
    • Thai (Thailand)
      ไทย
  • About STADA
  • Products
  • Contact
Back
  • About STADA
  • Who we are – STADA Thailand
  • Management
  • Our Corporate Culture
Back
  • Products
  • Products overview
  • Quality at STADA TH
Back

STADA set to expand Specialty portfolio

With positive CHMP opinion on KinpeygoTM orphan medicine for IgAN kidney disease

Read more

Caring for People's Health as a Trusted Partner

STADA: Caring for people’s health as a trusted partner

Read more

Coronavirus (COVID-19)

As STADA we are "Caring for people‘s health as a trusted partner"

Read more

Explore our news

20.05.2022
STADA set to expand Specialty portfolio with positive CHMP opinion on Kinpeygo orphan medicine for IgAN kidney disease

STADA has taken a significant step towards expanding its Specialty portfolio

Read more

01.11.2022
STADA and Xbrane secure EU approval for Ximluci® (ranibizumab) biosimilar referencing Lucentis®
  • European Commission grants pan-EU marketing authorization for Ximluci® biosimilar referencing Lucentis® (ranibizumab)

  • Paves way for Europ…

Read more

12.03.2020
STADA delivers double-digit growth in 2019 as it invests to lead Consumer Healthcare and Generics core segments

Read more

20.04.2020
Corona Survey

Insights into how people in four major European countries are feeling about healthcare issues amid the COVID-19 crises.

Read more

09.04.2020
STADA responds to urgent need by making more medicines

March 2020 saw the highest production output in STADA’s 125-year history as the COVID-19 crisis significantly raised demand for critical med…

Read more

125 years STADA

This year is a very special year for STADA: STADA Arzneimittel AG was founded 125 years ago! According to pharmacy historians, STADA's zero hour is March 14, 1895. Forward-looking pharmacists team up to economically produce joint preparations. STADA´s story begins. With a long-standing heritage rooted in pharmacies we are “Caring for people´s health as a trusted partner”.

Digital health knowledge

We are convinced that if you want to stay healthy, you cannot do without one thing: Health knowledge. Because of this, we have set ourselves the goal of raising awareness of health issues. Our blog "www.yourhealth.stada" offers helpful tips.

Go to STADA Health Blog

STADA Generics and Specialties

Generics and Specialties

One of STADA's important business areas is the production and sales of inexpensive medicines that are generally known as generics. This area also includes specialties like biosimilars.

Read more

Quality at STADA

Quality and responsibility to all who use our products or services is a fundamental part of our corporate strategy.

Company

STADA is a company with a focus on the healthcare market.

Generics & Consumer Health Products

The foundation of STADA’s growth story rests on two pillars: generics, including specialty pharmaceuticals and biosimilars, and non-prescription consumer healthcare products. Worldwide, STADA Group sells its products in approximately 120 countries.

Our company truly values people on a personal level which inspires me to grow and show my potential.

Adam Valent

Global Product Manager Biosimilars

Career at STADA

Are you looking for a job in a pharmaceutical company? Learn more about the STADA Group and the opportunities offered by an international company.

Career at STADA

Are you looking for a job in a pharmaceutical company? Learn more about the STADA Group and the opportunities offered by an international company.

Our company truly values people on a personal level which inspires me to grow and show my potential.

Adam Valent

Global Product Manager Biosimilars

Products
  • Zoflora®
  • Oilatum®
  • Sinulan Allergy Forte
  • Sinulan Express Forte
  • Stadent
Products
  • Zoflora®
  • Oilatum®
  • Sinulan Allergy Forte
  • Sinulan Express Forte
  • Stadent
Company
  • About STADA
  • About our products
  • Contact
Company
  • About STADA
  • About our products
  • Contact
Get in Touch
  • Contact
  • +66 2 059 7420
FOLLOW US

Conditions of Use

Privacy Policy

Imprint

Progenerika logo

© Copyright STADA Arzneimittel AG 2025